Joshua J. Meeks, MD, PhD, is an associate professor of urology, biochemistry, and molecular genetics at the Northwestern University Feinberg School of Medicine and section chief of robotic surgery at the Jesse Brown Department of Veterans Affairs Medical Center in Chicago, Illinois. His expertise is in diagnosing, treating, and managing bladder cancer. ...
Expert Interviews
Advertisement
GU Oncology Now spoke with Shyam Natarajan to discuss Avenda's iQuest and how AI can be used in the field of cancer care.
Cytoreductive nephrectomy is controversial in the metastatic RCC setting, especially in the age of immunotherapy.
Alexander Kutikov speaks about changes he pioneered in the GU surgical landscape and the future state of GU oncology care.
Colin Dinney, MD, explains the data that led to FDA approval of Adstiladrin for NMIBC and how it impacts the treatment.
Tomi Jun, MD, shares the clinical actionability and utilization of NGS for prostate cancer in a changing treatment landscape.
Dr. Daniel Tennenbaum interviews Dr. Catherine H. Marshall on trends in managing advanced and metastatic prostate cancer.
Advertisement
